FILGOTINIB, AN ORAL JAK1 SELECTIVE INHIBITOR WITH A RAPID ONSET OF ACTION: RESULTS FROM THE DARWIN 1 STUDY IN METHOTREXATE INADEQUATE RESPONSE RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Taylor, Peter C. [1 ]
Westhovens, Rene [2 ]
Vyncke, Veerle [3 ]
Meuleners, Luc [4 ]
Van der Aa, Annegret [4 ]
Harrison, Pille [4 ]
Tasset, Chantal [3 ]
机构：
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[2] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Ctr, Leuven, Belgium
[3] Galapagos, Dev Portfolio Management, Mechelen, Belgium
[4] Galapagos, Clin Dev, Mechelen, Belgium
来源：
RHEUMATOLOGY | 2017年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O02
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] EFFECTS OF THE JAK1-SELECTIVE INHIBITOR FILGOTINIB ON MULTIBIOMARKER DISEASE ACTIVITY SCORES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE
    Genovese, M. C.
    Li, W.
    Goyal, L.
    Pan, Y.
    Van der Aa, A.
    Jamoul, C.
    Harrison, P.
    Tasset, C.
    Gallen, R.
    Tarrant, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 281 - 281
  • [2] SAFETY AND EFFICACY OF ABT-494, A NOVEL SELECTIVE JAK1 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
    Genovese, M. C.
    Smolen, J. S.
    Weinblatt, M. E.
    Meerwein, S.
    Camp, H. S.
    Wang, L.
    Othman, A. A.
    Khan, N.
    Jungerwirth, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 141 - 142
  • [3] Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
    Westhovens, R.
    Taylor, P. C.
    Alten, R.
    Pavlova, D.
    Enriquez-Sosa, F.
    Mazur, M.
    Greenwald, M.
    Van der Aa, A.
    Vanhoutte, F.
    Tasset, C.
    Harrison, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 998 - 1008
  • [4] Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor Is Effective in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: Results from a Phase 2B Dose Ranging Study
    Westhovens, R.
    Alten, Rieke
    Pavlova, Dace
    Enriquez-Sosa, Favio
    Mazur, Minodora
    Greenwald, Maria
    Van der Aa, Annegret
    Vanhoutte, Frederic
    Tasset, Chantal
    Harrison, Pille
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid Arthritis
    Singh, Jasvinder A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (04): : 309 - 311
  • [6] Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)
    Kavanaugh, A.
    Kremer, J.
    Ponce, L.
    Cseuz, R.
    Reshetko, O. V.
    Stanislavchuk, M.
    Greenwald, M.
    Van der Aa, A.
    Vanhoutte, F.
    Tasset, C.
    Harrison, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 1009 - 1019
  • [7] Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: FINCH 1 Primary Outcome Results
    Keystone, Edward
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lie
    Guo, Ying
    Tasset, Chantal
    Sundy, John
    Mozaffarian, Neelufar
    Landewe, Robert
    Bae, Sang-Cheol
    Nash, Peter
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1108 - 1108
  • [8] Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
    Mark Genovese
    Rene Westhovens
    Luc Meuleners
    Annegret Van der Aa
    Pille Harrison
    Chantal Tasset
    Arthur Kavanaugh
    Arthritis Research & Therapy, 20
  • [9] Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
    Genovese, Mark
    Westhovens, Rene
    Meuleners, Luc
    Van der Aa, Annegret
    Harrison, Pille
    Tasset, Chantal
    Kavanaugh, Arthur
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [10] FILGOTINIB, A SELECTIVE JANUS KINASE 1 (JAK1) INHIBITOR, MODULATES DISEASE-ASSOCIATED CYTOKINES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    Taylor, Peter C.
    Elboudwarej, Emon
    LI Wanying
    Hawtin, Rachael E.
    Liu, Jinfeng
    Mirza, Amer M.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 736 - 736
12345